ArticleCancer immunology, immunotherapy : CII2021

BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes.

Lukas Peiffer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.